000			02298 a2200673 4500
005			20250517170901.0
264		0	_c20171002
008			201710s 0 0 eng d
022			_a1474-4457
024	7		_a10.1016/S1473-3099(17)30496-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aForns, Xavier
245	0	0	_aGlecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. _h[electronic resource]
260			_bThe Lancet. Infectious diseases _c10 2017
300			_a1062-1068 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAminoisobutyric Acids
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aBenzimidazoles _xadministration & dosage
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xclassification
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aLeucine _xanalogs & derivatives
650	0	4	_aLiver Cirrhosis _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aPyrrolidines
650	0	4	_aQuinoxalines _xadministration & dosage
650	0	4	_aSulfonamides _xadministration & dosage
700	1		_aLee, Samuel S
700	1		_aValdes, Joaquin
700	1		_aLens, Sabela
700	1		_aGhalib, Reem
700	1		_aAguilar, Humberto
700	1		_aFelizarta, Franco
700	1		_aHassanein, Tarek
700	1		_aHinrichsen, Holger
700	1		_aRincon, Diego
700	1		_aMorillas, Rosa
700	1		_aZeuzem, Stefan
700	1		_aHorsmans, Yves
700	1		_aNelson, David R
700	1		_aYu, Yao
700	1		_aKrishnan, Preethi
700	1		_aLin, Chih-Wei
700	1		_aKort, Jens J
700	1		_aMensa, Federico J
773	0		_tThe Lancet. Infectious diseases _gvol. 17 _gno. 10 _gp. 1062-1068
856	4	0	_uhttps://doi.org/10.1016/S1473-3099(17)30496-6 _zAvailable from publisher's website
999			_c27475752 _d27475752